Dong,J.; Wang, Z.; Meng, Q.; Zhang, Q.; Huang, G.; Cui, J.; Li,S. "Development of 2-arylbenzo[h]quinolone analogs as selective CYP1B1 inhibitors." RSC Advances, 2018, 8, 15000-15020.
·Huang, G.; Zhao, H.; Meng, Q.; Zhang, Q.; Dong, J.; Zhu, B.; Li, S. "Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents." Eur. J. Med. Chem., 2018, 143, 166-181.
·Meng,Q.; Liu, Z.; Li, S. "Prediction and Early Evaluation of Anticancer Therapy Response: From Imaging of Drug Efflux Pumps to Targeted Therapy Response." Curr. Med. Chem., 2016, 23, 4625-4638.
·Cui, J.; Meng, Q.; Zhang, X.; Cui, Q.; Zhou, W.; Li, S. Design and synthesis of new α-naphthoflavones as cytochrome P450 (CYP) 1B1 inhibitors to overcome docetaxel-resistance associated with CYP1B1 overexpression. J. Med. Chem., 2015, 58(8), 3534-3547
·Cui, J.; Li, S. “Inhibitors and Prodrugs Targeting CYP1: A Novel Approach in Cancer Prevention and Therapy.” Curr. Med. Chem., 2014, 21, 519-552.